Schedule 13D ownership disclosure
Tevogen Bio Holdings Inc
Common Stock, par value $0.0001 per share · CUSIP: 88165K101
Event date: 2025-06-27
- Filing-level shares
- 125,008,376.32
- Percent of class
- 64.5%
- Ryan H. SaadiReported CIK 0002011728
Shares: 125,008,376.32 · Class: 64.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001641172-25-021070
- Form type
- SCHEDULE 13D/A
- Filer
- Saadi Ryan H.
- CIK
- CIK 2011728
- Filed
- Jul 25, 2025
- Reporting period
- Jun 27, 2025
- Description
- Schedule 13D beneficial ownership